vs
Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $70.6M, roughly 1.1× Viridian Therapeutics, Inc.\DE). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -49.0%, a 52.5% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $-84.7M).
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
IVT vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.4M | $70.6M |
| Net Profit | $2.7M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -11.0% | -56.7% |
| Net Margin | 3.4% | -49.0% |
| Revenue YoY | 8.6% | 81958.1% |
| Net Profit YoY | -72.8% | 54.9% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $77.4M | — | ||
| Q3 25 | $74.5M | $70.6M | ||
| Q2 25 | $73.6M | — | ||
| Q1 25 | $73.8M | — | ||
| Q4 24 | $71.2M | — | ||
| Q3 24 | $68.5M | — | ||
| Q2 24 | $67.4M | — | ||
| Q1 24 | $66.8M | — |
| Q4 25 | $2.7M | — | ||
| Q3 25 | $6.0M | $-34.6M | ||
| Q2 25 | $95.9M | — | ||
| Q1 25 | $6.8M | — | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-539.0K | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | -11.0% | — | ||
| Q3 25 | -9.8% | -56.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | -10.5% | — | ||
| Q4 24 | -3.6% | — | ||
| Q3 24 | -18.7% | — | ||
| Q2 24 | -13.6% | — | ||
| Q1 24 | -13.1% | — |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 8.1% | -49.0% | ||
| Q2 25 | 130.4% | — | ||
| Q1 25 | 9.2% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 4.3% | — |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.08 | — | ||
| Q2 25 | $1.23 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.14 | — | ||
| Q3 24 | $-0.01 | — | ||
| Q2 24 | $0.02 | — | ||
| Q1 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $825.9M | — |
| Stockholders' EquityBook value | $1.8B | $503.0M |
| Total Assets | $2.8B | $577.1M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $825.9M | — | ||
| Q3 25 | $764.6M | — | ||
| Q2 25 | $746.3M | — | ||
| Q1 25 | $740.7M | — | ||
| Q4 24 | $740.4M | — | ||
| Q3 24 | $740.1M | — | ||
| Q2 24 | $812.2M | — | ||
| Q1 24 | $827.5M | — |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.8B | $503.0M | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.7B | $577.1M | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.42× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.4M | $-84.6M |
| Free Cash FlowOCF − Capex | $110.9M | $-84.7M |
| FCF MarginFCF / Revenue | 143.3% | -120.1% |
| Capex IntensityCapex / Revenue | 57.5% | 0.2% |
| Cash ConversionOCF / Net Profit | 58.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $193.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $155.4M | — | ||
| Q3 25 | $43.8M | $-84.6M | ||
| Q2 25 | $48.7M | — | ||
| Q1 25 | $20.2M | — | ||
| Q4 24 | $136.9M | — | ||
| Q3 24 | $38.4M | — | ||
| Q2 24 | $46.7M | — | ||
| Q1 24 | $14.8M | — |
| Q4 25 | $110.9M | — | ||
| Q3 25 | $31.4M | $-84.7M | ||
| Q2 25 | $38.0M | — | ||
| Q1 25 | $12.8M | — | ||
| Q4 24 | $100.8M | — | ||
| Q3 24 | $29.3M | — | ||
| Q2 24 | $37.2M | — | ||
| Q1 24 | $7.7M | — |
| Q4 25 | 143.3% | — | ||
| Q3 25 | 42.2% | -120.1% | ||
| Q2 25 | 51.6% | — | ||
| Q1 25 | 17.4% | — | ||
| Q4 24 | 141.5% | — | ||
| Q3 24 | 42.8% | — | ||
| Q2 24 | 55.2% | — | ||
| Q1 24 | 11.5% | — |
| Q4 25 | 57.5% | — | ||
| Q3 25 | 16.7% | 0.2% | ||
| Q2 25 | 14.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 50.7% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 10.6% | — |
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
